Results 101 to 110 of about 1,019 (188)

Deguelin`in deneysel meme kanseri tedavisindeki etkinliğinin araştırılması

open access: yes, 2021
Breast cancer is the second most common type of cancer among women in the USA and it is one of the most studied cancer type in the world. As an alternative for the standard treatment used in breast cancer there is a need for agents which are more potent and have less toxicity.
openaire   +1 more source

Deguelol, a deguelin derivative, inhibits angiogenesis through down-regulation of Hypoxia-inducible factor-1α stability and AKT signaling

open access: yes, 2012
학위논문 (석사)-- 서울대학교 대학원 : 분자의학 및 바이오제약학과, 2012. 2. 김규원.Deguelin, one compound extracted from several plants, binds ATP-binding site of HSP90 and regulates its activity.
김경석
core  

Correction: Deguelin inhibits growth and prolactin synthesis in prolactinomas by targeting the PI3K/AKT/CREB3L1 pathway and ornithine decarboxylase. [PDF]

open access: yesActa Pharmacol Sin
Gong L   +13 more
europepmc   +1 more source

Correction: A Novel Derivative of Deguelin [PDF]

open access: yesCancer Prevention Research, 2009
openaire   +1 more source

Deguelin regulates cell cycle and nuclear pore complex protein Nup98 and Nup88 in U937 cells in vitro

open access: yes, 2007
OBJECTIVE: To investigate antitumor activity and molecular mechanism of deguelin to the human U937 leukaemia cells and to explore the mechanisms regulating cell cycle and nucleoporin 98 (Nup98) and nucleoporin 88 (Nup88) in vitro. METHODS: The effects of
Chen, WH   +5 more
core  

Deguelin inhibits growth and prolactin synthesis in prolactinomas by targeting the PI3K/AKT/CREB3L1 pathway and ornithine decarboxylase. [PDF]

open access: yesActa Pharmacol Sin
Gong L   +13 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy